Matthew Milowsky

25PUBLICATIONS
185CO-AUTHORS
Natural language processingMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Mar 27, 2026
Repeatability of Semi-Quantitative and Volumetric Features from Artificial-Intelligence-Guided Lesion Segmentation on 18F-DCFPyL PSMA-PET/CT Images: Results from a Test-Retest Cohort.

Md Zobaer Islam, Timothy G Perk, Amy Weisman

|Feb 27, 2026
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial.

Matthew D Galsky, Charlene Mantia, Michaela Bowden

|Dec 13, 2025
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling.

Michael S Sturdivant, Andrew S Truong, Mi Zhou

|Dec 13, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.

Rana R McKay, Sumanta Pal, Wanling Xie

|Oct 01, 2025
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study.

Amanda Nizam, Charles B Nguyen, Jinju Li

|Aug 07, 2025
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial.

Matthew D Galsky, Dean F Bajorin, Yoshihiko Tomita

Pageof 5

Frequent Collaborators

7 joint publications

Matthew Galsky

5 joint publications

William Y Kim

4 joint publications

Jeffrey S Damrauer

4 joint publications

Tian Zhang